{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:33:43Z","timestamp":1786649623441,"version":"build-2736575974"},"update-to":[{"DOI":"10.4103\/jpat_20121603_342","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000}}],"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The biological mechanism(s) that guide the immunological effectors of lymphocytes to sites of inflammatory response, a feature consistently seen in oral submucous fibrosis (OSF) was evaluated. It is envisaged that endothelial\/lymphocyte adhesion cascades involving VCAM-1\/\u03b14\u03b21 integrins control the migration of lymphocytes across the vascular endothelium resulting in their homing in these locales.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      The study group comprised 28 OSF cases (M:F = 12:16, age range 18-65 years; mean 55.4 \u00b1 8.5 SD) divided into early (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =17) and advanced (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =11) disease groups. Biopsy specimens of normal buccal mucosa (site compatible) were obtained from 10 healthy volunteers (age and sex matched) who served as control. All the samples were fixed in 10% neutral-buffered formalin and embedded in paraffin. Immunolocalization of \u03b21 subunit associated with \u03b14 integrin was performed by a mouse heterodimer (clone 4B7R, Ig G, R &amp; D Systems Inc., dilution 1:100) using a peroxidase labeled streptavidin\u2013biotin technique. The immunocompetent cell density was expressed as the number of positive cells per mm\n                      <jats:sup>2<\/jats:sup>\n                      . The Mann\u2013Whitney\n                      <jats:italic toggle=\"yes\">U<\/jats:italic>\n                      -test and Fischer exact test were used to evaluate differences.\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05 was considered to be significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The median percentage of \u201cT\u201d lymphocytes with positive integrin \u03b14\u03b21 expression was 77.7 (an interquartile range of 73.3\u201383.4) for the test cases and for the controls, it was 28.2 (IQR 24.0\u201338.3). This difference was significant at 0.001 level. For the endothelial cells the positive expression was 82.8 (IQR 77\u201390.6) and 22.3 (IQR 18.3\u201329.2) respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). When the intensity of integrin expression was considered 26\/28 cases (96%) and 2\/10 (20%) of controls showed intense expression of integrins \u03b14\u03b21 on T lymphocytes (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Similarly, 27\/28 cases (92.9%) and 2\/10 (20%) of controls showed intense expression on endothelial cells (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). T lymphocyte\u2013endothelial cell interactions were assessed by evaluating the overexpression of integrins on both the endothelial cells and lymphocytes together. The interaction was positive in 15\/17 and 11\/11 early and advanced OSF cases respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.51).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Following leukocyte activation, the interaction between leukocyte integrin heterodimers and endothelial superfamily adhesion ligands results in a firm adherence of leukocytes to endothelium, leading to leukocyte migration and homing to sites of mucosal inflammation consistently seen in OSF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0973-029x.86678","type":"journal-article","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T04:46:57Z","timestamp":1319518017000},"page":"272-277","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["\u03b14\u03b21 integrin-dependent cell sorting dictates T-cell recruitment in oral submucous fibrosis"],"prefix":"10.4103","volume":"15","author":[{"given":"R","family":"Rajendran","sequence":"first","affiliation":[{"name":"Departments of Oral Medicine and Diagnostic Science, College of Dentistry, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Deepthi","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology, Government Dental College, Trivandrum, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Nooh","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, College of Dentistry, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukumaran","family":"Anil","sequence":"additional","affiliation":[{"name":"Department of Periodontics and Community Dentistry, and Dental Implant and Osseointegration Research Chair, College of Dentistry, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","updated-by":[{"DOI":"10.4103\/0973-029x.102529","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"record-id":"2612"},{"DOI":"10.4103\/jpat_20121603_342","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000}}],"container-title":["Journal of Oral and Maxillofacial Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01233803-201115030-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:56:12Z","timestamp":1786647372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01233803-201115030-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.4103\/0973-029x.86678","relation":{},"ISSN":["0973-029X","1998-393X"],"issn-type":[{"value":"0973-029X","type":"print"},{"value":"1998-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}